Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Scharvik/Getty ...
CARB-X announced today that it’s awarding $1.2 million to a research team at Harvard University to develop enhanced ...
The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, ...
Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results